+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day

A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day

Journal of Clinical Pathology 71(9): 757-762

(PDF emailed within 0-6 h: $19.90)

Accession: 049795732

Download citation: RISBibTeXText

PMID: 29903742

DOI: 10.1136/jclinpath-2018-205189

Related references

Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches. Clinical Cancer Research 21(16): 3631-3639, 2016

Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterations. Annals of Oncology 28(4): 748-753, 2017

Liquid Biopsy to Identify Actionable Genomic Alterations. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 2018(38): 978-997, 2018

Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. Journal of Clinical Oncology 31(25): 3133-3140, 2013

Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel. Oncotarget 7(44): 71686-71695, 2016

A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory. Oncotarget 8(26): 41806-41814, 2017

Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas. Oncotarget 8(24): 39254-39267, 2017

The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients. Clinical Cancer Research 24(15): 3528-3538, 2018

Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations. Clinical Cancer Research 22(24): 6061-6068, 2016

Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations. Cancer 122(1): 20-33, 2016

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer Discovery 2(1): 82-93, 2013

A multiplex technology platform for the rapid analysis of clinically actionable genetic alterations and validation for BRAF p.V600E detection in 1549 cytologic and histologic specimens. Archives of Pathology and Laboratory Medicine 138(3): 371-378, 2014

The assessment of genomic alterations using DNA arrays following traumatic brain injury: a review. Restorative Neurology and Neuroscience 18(2-3): 105-113, 2002

Cross-platform assessment of genomic imbalance confirms the clinical relevance of genomic complexity and reveals loci with potential pathogenic roles in diffuse large B-cell lymphoma. Leukemia and Lymphoma 57(4): 899-908, 2016

BTECH: a platform to integrate genomic, transcriptomic and epigenomic alterations in brain tumors. Neuroinformatics 9(1): 59-67, 2011